share_log
Benzinga ·  10/09 08:07

Windtree Therapeutics Shares Are Trading Higher After the Company Announced That the Trial Design of Its SEISMiC Phase 2b Has Been Published by the European Society of Cardiology Heart Failure

windtree therapeutics股价上涨,公司宣布其SEISMiC第20亿期试验设计已被欧洲心脏病学会心力衰竭发表

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发